Immunotherapy Clinical Trial Reveals Brain Tumor Shrinkage, Continues with Phase 3 Study – Newswise (press release)
|
Immunotherapy Clinical Trial Reveals Brain Tumor Shrinkage, Continues with Phase 3 Study
Newswise (press release) Newswise — Following successful Phase 1 clinical trials, the Toca regimen – a new immunotherapy for patients with recurrent brain cancer – has advanced to a Phase 3 study, which is currently underway. The trial is being conducted at 68 sites across … |
